CS logo
small CS logo
Peripheral Neuropathy Center, Neurological Institue Building, Columbia University Medical Center

New York, New York, United States
Neurosurgeon in New York City, New York
710 W 168th St, New York, NY 10032

About Peripheral Neuropathy Center, Neurological Institue Building, Columbia University Medical Center


The Neurological Institute of New York, is an American hospital research center located at 710 West 168th Street at the corner of Fort Washington Avenue in the NewYork-Presbyterian Hospital / Columbia University Medical Center in the Washington Heights neighborhood of Manhattan, New York City.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Peripheral Neuropathy Center, Neurological Institue Building, Columbia University Medical Center


During the past decade, Peripheral Neuropathy Center, Neurological Institue Building, Columbia University Medical Center conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Peripheral Neuropathy Center, Neurological Institue Building, Columbia University Medical Center" #1 collaborator was "Premier Research Group plc" with 1 trials as a collaborator, "Syneos Health" with 1 trials as a collaborator and "SynteractHCR" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

Clinical Trials Conditions at Peripheral Neuropathy Center, Neurological Institue Building, Columbia University Medical Center


According to Clinical.Site data, the most researched conditions in "Peripheral Neuropathy Center, Neurological Institue Building, Columbia University Medical Center" are "Charcot-Marie-Tooth Disease Type 1A" (1 trials) and "Charcot-Marie-Tooth Disease, Type IA" (1 trials). Many other conditions were trialed in "Peripheral Neuropathy Center, Neurological Institue Building, Columbia University Medical Center" in a lesser frequency.

Clinical Trials Intervention Types at Peripheral Neuropathy Center, Neurological Institue Building, Columbia University Medical Center


Most popular intervention types in "Peripheral Neuropathy Center, Neurological Institue Building, Columbia University Medical Center" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "PXT3003" (1 trials), "PXT3003 dose 1" (1 trials), "PXT3003 dose 2" (1 trials) and "placebo" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Peripheral Neuropathy Center, Neurological Institue Building, Columbia University Medical Center


The vast majority of trials in "Peripheral Neuropathy Center, Neurological Institue Building, Columbia University Medical Center" are 2 trials for "All" genders.

Clinical Trials Status at Peripheral Neuropathy Center, Neurological Institue Building, Columbia University Medical Center


Currently, there are NaN active trials in "Peripheral Neuropathy Center, Neurological Institue Building, Columbia University Medical Center". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Peripheral Neuropathy Center, Neurological Institue Building, Columbia University Medical Center, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Peripheral Neuropathy Center, Neurological Institue Building, Columbia University Medical Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".